|
SIPARI® is a
directed music-supported treatment approach developed to improve language
and speech capabilities of patients suffering from chronic aphasia. This method is made up specifically of Singing, Intonation, Prosody,
breathing (German: Atmung), Rhythm, and Improvisation as essential elements.
SIPARI® was developed by Dr. Jungblut and
has been tried and tested in cooperation with the Medical Faculty of of the University of Witten-Herdecke,
Germany.
In a randomized controlled group study with
patients suffering from chronic non-fluent aphasia (mean duration of
aphasia: 11 years) significant improvements of 75% of all patients were
assessed by a standardized language procedure, the Aachener
Aphasie Test (AAT).
Meanwhile further single case
studies substantiate the extraordinary efficacy of SIPARI® in the treatment of severely
impaired chronic aphasia patients and also patients who additionally suffer
from apraxia of speech.
Since 2010 SIPARI® is listed in the Cochrane
Review “Music therapy for acquired brain injury” in the
category “communication” as the only evidence-based method. ref.: Bradt J, Magee WL,
Dileo C, Wheeler BL, McGilloway
E. Music therapy for acquired brain injury. Cochrane Database of Systematic
Reviews 2010, Issue 7. Art. No.: CD006787. DOI: 10.1002/14651858.
CD006787.pub2.
|